Nisa Investment Advisors LLC Sells 5,944 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Nisa Investment Advisors LLC lessened its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 8.1% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 67,033 shares of the company’s stock after selling 5,944 shares during the period. Nisa Investment Advisors LLC’s holdings in HCA Healthcare were worth $20,120,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in HCA. Benjamin F. Edwards & Company Inc. purchased a new stake in shares of HCA Healthcare in the 2nd quarter worth $33,000. Legacy Investment Solutions LLC bought a new position in shares of HCA Healthcare in the third quarter worth about $39,000. Canoe Financial LP bought a new position in shares of HCA Healthcare during the 3rd quarter valued at approximately $41,000. Capital Performance Advisors LLP bought a new stake in HCA Healthcare during the 3rd quarter worth approximately $41,000. Finally, Northwest Investment Counselors LLC purchased a new stake in shares of HCA Healthcare in the third quarter worth $44,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the stock. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $392.00 target price on shares of HCA Healthcare in a report on Tuesday, October 1st. Oppenheimer lifted their target price on HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research note on Monday, October 28th. KeyCorp cut their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a report on Tuesday, January 7th. Raymond James lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. Finally, StockNews.com cut shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $385.27.

HCA Healthcare Trading Up 0.3 %

Shares of HCA opened at $319.53 on Thursday. HCA Healthcare, Inc. has a twelve month low of $278.68 and a twelve month high of $417.14. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The company’s fifty day simple moving average is $315.10 and its 200-day simple moving average is $353.07. The company has a market cap of $80.94 billion, a P/E ratio of 14.35, a P/E/G ratio of 1.06 and a beta of 1.64.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, December 27th. Stockholders of record on Friday, December 13th were issued a $0.66 dividend. The ex-dividend date was Friday, December 13th. This represents a $2.64 annualized dividend and a dividend yield of 0.83%. HCA Healthcare’s payout ratio is 11.85%.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares in the company, valued at $18,445,700. This represents a 6.89 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now owns 6,843 shares in the company, valued at $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.70% of the stock is owned by company insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.